Search alternatives:
26 decrease » 026 decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
d decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ 26 » _ 2 (Expand Search), _ 6 (Expand Search), _ 24 (Expand Search)
26 decrease » 026 decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
d decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ 26 » _ 2 (Expand Search), _ 6 (Expand Search), _ 24 (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription.
Published 2013“…(<i>D</i>) WNT3 decreased Gli1, and <i>Ptch1</i> mRNA levels after 6 h of treatment (Con=1; WNT3: Gli1=0.56±0.10, Gli2=0.90±0.10, Mycn= 0.99±0.05, <i>Ptch1</i>=0.58±0.09, and <i>Ccnd1</i>=0.89±0.09). …”
-
8
-
9
-
10
-
11
-
12
-
13
Multiple mechanisms decrease the Wee1/Cdc25 ratio during the transition into the second cycle.
Published 2014“…<p>(A) Schematic depiction of the decrease of Mos/MEK/MAPK activity, and the increase of Cdc25A concentration, during the first cycle. …”
-
14
-
15
-
16
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
-
17
-
18
-
19
Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema
Published 2021“…<b><i>Results:</i></b> Mean number of attacks/month significantly decreased (95% credible interval [CrI] excluding 0) from 1.15 preintervention to 0.25 and 0.23, 8 and 14 months within intervention, with mean decreases of −0.89 (95% CrI: −1.21 to −0.58) and −0.92 (95% CrI: −1.22 to −0.60), respectively. …”
-
20